You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Cancer Care Ontario GCSF Recommendations 2016

ID: GL-C50-27 Mar 2016
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
CCO Drug Formulary, GCSF Working Group

Guideline Objective

These are recommendations regarding the use of granulocyte colony-stimulating factor (G-CSF) for the primary prophylaxis of febrile neutropenia (FN) in adult patients. Additionally, antibiotic, antifungal, and antiviral prophylaxis will be discussed where applicable.

Intended Guideline Users

Providers (Physicians, Pharmacists, Nurses)

pdf download Full Report (PDF) (590.9 KB)